Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Nature Immunology|June 1, 2023
HLA class I signal peptide polymorphism determines the level of CD94/NKG2-HLA-E-mediated regulation of effector cell responsesZhansong Lin, Arman A Bashirova, Mathias Viard, et al.
Nature Communications|July 14, 2022
Natural Killer cells demonstrate distinct eQTL and transcriptome-wide disease associations, highlighting their role in autoimmunityJames J Gilchrist, Seiko Makino, Vivek Naranbhai, et al.
Journal of Virology|December 15, 2017
HLA Class I-Mediated HIV-1 Control in Vietnamese Infected with HIV-1 Subtype A/ETakayuki Chikata, Giang Van Tran, Hayato Murakoshi, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individualsVivek Naranbhai, Anusha Nathan, Clarety Kaseke, et al.
Molecular Cell|July 2, 2026
Cytosolic EZH2-IMPDH2 complexes regulate melanoma progression and metastasis via GTPGamze Kuser-Abali, Fumihito Noguchi, Peinan Zhao, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variantWilfredo F Garcia-Beltran, Kerri J St Denis, Angelique Hoelzemer, et al.
Cell|February 24, 2022
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individualsVivek Naranbhai, Anusha Nathan, Clarety Kaseke, et al.
Cell|July 15, 2021
Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecovirusesAnusha Nathan, Elizabeth J Rossin, Clarety Kaseke, et al.
The Journal of Investigative Dermatology|May 23, 2022
Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Pharmacovigilance StudyThomas K Le, Isabelle Brown, Rebecca Goldberg, et al.
Pageof 10